Warrants Finder
Your selection:
426 Results
| JE0U19 | Vertex Pharmaceuticals Inc./OS/Call [500]/JPMD | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 40.424% | 0.525 | -0.119 | 5.500 | 12/18/2026 | 0.100 | JP Morgan | ||
| JE11YS | Vertex Pharmaceuticals Inc./OS/Call [500]/JPMD | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 42.376% | 0.560 | -0.100 | 4.191 | 03/19/2027 | 0.100 | JP Morgan | ||
| JE84GW | Vertex Pharmaceuticals Inc./OS/Call [500]/JPMD | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 41.524% | 0.583 | -0.085 | 3.671 | 06/17/2027 | 0.100 | JP Morgan | ||
| JY3LSJ | Vertex Pharmaceuticals Inc./OS/Call [500]/JPMD | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 46.414% | 0.431 | -0.284 | 10.833 | 08/21/2026 | 0.100 | JP Morgan | ||
| MJ860V |  | Vertex Pharmaceuticals Inc./OS/Call [500]/MS | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 40.163% | 0.524 | -0.012 | 5.534 | 12/18/2026 | 0.010 | Morgan Stanley | |
| MK9KV0 | | Vertex Pharmaceuticals Inc./OS/Call [500]/MS | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 41.386% | 0.583 | -0.008 | 3.682 | 06/17/2027 | 0.010 | Morgan Stanley | |
| MM5JNZ | | Vertex Pharmaceuticals Inc./OS/Call [500]/MS | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 40.930% | 0.462 | -0.018 | 8.757 | 09/18/2026 | 0.010 | Morgan Stanley | |
| MN04AF | | Vertex Pharmaceuticals Inc./OS/Call [500]/MS | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 44.178% | 0.619 | -0.007 | 2.876 | 12/17/2027 | 0.010 | Morgan Stanley | |
| MN6FTB | | Vertex Pharmaceuticals Inc./OS/Call [500]/MS | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 41.915% | 0.560 | -0.010 | 4.229 | 03/19/2027 | 0.010 | Morgan Stanley | |
| SX5K5E | Vertex Pharmaceuticals Inc./OS/Call [500]/SOC | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 39.579% | 0.535 | -0.109 | 5.152 | 01/15/2027 | 0.100 | Société Générale | ||
| SX5KSN | Vertex Pharmaceuticals Inc./OS/Call [500]/SOC | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 39.883% | 0.459 | -0.180 | 8.989 | 09/18/2026 | 0.100 | Société Générale | ||
| FA53KA | Vertex Pharmaceuticals Inc./OS/Call [500]/SOC | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 39.068% | 0.523 | -0.116 | 5.671 | 12/18/2026 | 0.100 | Société Générale | ||
| FD1ZF8 | Vertex Pharmaceuticals Inc./OS/Call [500]/SOC | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 41.052% | 0.558 | -0.097 | 4.310 | 03/19/2027 | 0.100 | Société Générale | ||
| FE58U1 | Vertex Pharmaceuticals Inc./OS/Call [500]/SOC | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 40.183% | 0.581 | -0.083 | 3.777 | 06/17/2027 | 0.100 | Société Générale | ||
| FE58U6 | Vertex Pharmaceuticals Inc./OS/Call [500]/SOC | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 40.373% | 0.595 | -0.073 | 3.376 | 09/17/2027 | 0.100 | Société Générale | ||
| FE58VJ | Vertex Pharmaceuticals Inc./OS/Call [500]/SOC | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 39.820% | 0.616 | -0.064 | 3.035 | 01/21/2028 | 0.100 | Société Générale | ||
| FE58VA | Vertex Pharmaceuticals Inc./OS/Call [500]/SOC | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 40.006% | 0.610 | -0.066 | 3.115 | 12/17/2027 | 0.100 | Société Générale | ||
| VJ5DDF | | Vertex Pharmaceuticals Inc./OS/Call [500]/VONT | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 36.810% | 0.517 | -0.110 | 6.005 | 12/18/2026 | 0.100 | Vontobel | |
| VY41YX | | Vertex Pharmaceuticals Inc./OS/Call [500]/VONT | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 41.831% | 0.583 | -0.086 | 3.651 | 06/17/2027 | 0.100 | Vontobel | |
| VY5LY8 | | Vertex Pharmaceuticals Inc./OS/Call [500]/VONT | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 37.394% | 0.454 | -0.170 | 9.591 | 09/18/2026 | 0.100 | Vontobel | |
| GW3T1R | Vertex Pharmaceuticals Inc./OS/Call [520]/GOLDS | - | - | 520.000 | call | Vertex Pharmaceuticals Inc. | - | 37.256% | 0.470 | -0.102 | 5.792 | 01/15/2027 | 0.100 | Goldman Sachs | ||
| GW3ZYA | Vertex Pharmaceuticals Inc./OS/Call [520]/GOLDS | - | - | 520.000 | call | Vertex Pharmaceuticals Inc. | - | 38.092% | 0.502 | -0.091 | 4.845 | 03/19/2027 | 0.100 | Goldman Sachs | ||
| GW5B2C | Vertex Pharmaceuticals Inc./OS/Call [520]/GOLDS | - | - | 520.000 | call | Vertex Pharmaceuticals Inc. | - | 37.383% | 0.532 | -0.079 | 4.198 | 06/17/2027 | 0.100 | Goldman Sachs | ||
| JZ96U2 | Vertex Pharmaceuticals Inc./OS/Call [520]/JPMD | - | - | 520.000 | call | Vertex Pharmaceuticals Inc. | - | 42.353% | 0.376 | -0.179 | 9.293 | 09/18/2026 | 0.100 | JP Morgan | ||
| JE1XVC | Vertex Pharmaceuticals Inc./OS/Call [520]/JPMD | - | - | 520.000 | call | Vertex Pharmaceuticals Inc. | - | 39.746% | 0.408 | -0.144 | 7.986 | 10/16/2026 | 0.100 | JP Morgan | ||
| JE0WCN | Vertex Pharmaceuticals Inc./OS/Call [520]/JPMD | - | - | 520.000 | call | Vertex Pharmaceuticals Inc. | - | 40.150% | 0.464 | -0.117 | 5.880 | 12/18/2026 | 0.100 | JP Morgan | ||
| JE0URA | Vertex Pharmaceuticals Inc./OS/Call [520]/JPMD | - | - | 520.000 | call | Vertex Pharmaceuticals Inc. | - | 41.962% | 0.514 | -0.099 | 4.423 | 03/19/2027 | 0.100 | JP Morgan | ||
| JE84H6 | Vertex Pharmaceuticals Inc./OS/Call [520]/JPMD | - | - | 520.000 | call | Vertex Pharmaceuticals Inc. | - | 41.057% | 0.543 | -0.085 | 3.854 | 06/17/2027 | 0.100 | JP Morgan | ||
| JY0YG1 | Vertex Pharmaceuticals Inc./OS/Call [520]/JPMD | - | - | 520.000 | call | Vertex Pharmaceuticals Inc. | - | 40.509% | 0.482 | -0.110 | 5.331 | 01/15/2027 | 0.100 | JP Morgan | ||
| JY3QF9 | Vertex Pharmaceuticals Inc./OS/Call [520]/JPMD | - | - | 520.000 | call | Vertex Pharmaceuticals Inc. | - | 43.375% | 0.306 | -0.230 | 13.214 | 08/21/2026 | 0.100 | JP Morgan | ||
| SX5K5F | Vertex Pharmaceuticals Inc./OS/Call [520]/SOC | - | - | 520.000 | call | Vertex Pharmaceuticals Inc. | - | 38.135% | 0.475 | -0.104 | 5.653 | 01/15/2027 | 0.100 | Société Générale | ||
| FE1AXQ | Vertex Pharmaceuticals Inc./OS/Call [520]/SOC | - | - | 520.000 | call | Vertex Pharmaceuticals Inc. | - | 38.982% | 0.459 | -0.114 | 6.064 | 12/18/2026 | 0.100 | Société Générale | ||
| FE1AXV | Vertex Pharmaceuticals Inc./OS/Call [520]/SOC | - | - | 520.000 | call | Vertex Pharmaceuticals Inc. | - | 40.579% | 0.510 | -0.096 | 4.564 | 03/19/2027 | 0.100 | Société Générale | ||
| FE58HD | Vertex Pharmaceuticals Inc./OS/Call [520]/SOC | - | - | 520.000 | call | Vertex Pharmaceuticals Inc. | - | 39.566% | 0.365 | -0.166 | 10.012 | 09/18/2026 | 0.100 | Société Générale | ||
| FE58U2 | Vertex Pharmaceuticals Inc./OS/Call [520]/SOC | - | - | 520.000 | call | Vertex Pharmaceuticals Inc. | - | 39.761% | 0.539 | -0.083 | 3.968 | 06/17/2027 | 0.100 | Société Générale | ||
| FE58VK | Vertex Pharmaceuticals Inc./OS/Call [520]/SOC | - | - | 520.000 | call | Vertex Pharmaceuticals Inc. | - | 39.406% | 0.584 | -0.064 | 3.154 | 01/21/2028 | 0.100 | Société Générale | ||
| VH6279 | | Vertex Pharmaceuticals Inc./OS/Call [520]/VONT | - | - | 520.000 | call | Vertex Pharmaceuticals Inc. | - | 37.721% | 0.472 | -0.103 | 5.719 | 01/15/2027 | 0.100 | Vontobel | |
| GW527B | Vertex Pharmaceuticals Inc./OS/Call [540]/GOLDS | - | - | 540.000 | call | Vertex Pharmaceuticals Inc. | - | 36.771% | 0.411 | -0.097 | 6.220 | 01/15/2027 | 0.100 | Goldman Sachs | ||
| GW90LJ | Vertex Pharmaceuticals Inc./OS/Call [540]/GOLDS | - | - | 540.000 | call | Vertex Pharmaceuticals Inc. | - | 37.579% | 0.452 | -0.088 | 5.150 | 03/19/2027 | 0.100 | Goldman Sachs | ||
| GW95H1 | Vertex Pharmaceuticals Inc./OS/Call [540]/GOLDS | - | - | 540.000 | call | Vertex Pharmaceuticals Inc. | - | 36.920% | 0.488 | -0.077 | 4.425 | 06/17/2027 | 0.100 | Goldman Sachs | ||
| JE05DP | Vertex Pharmaceuticals Inc./OS/Call [540]/JPMD | - | - | 540.000 | call | Vertex Pharmaceuticals Inc. | - | 39.472% | 0.333 | -0.132 | 8.697 | 10/16/2026 | 0.100 | JP Morgan | ||
| JE0U18 | Vertex Pharmaceuticals Inc./OS/Call [540]/JPMD | - | - | 540.000 | call | Vertex Pharmaceuticals Inc. | - | 40.175% | 0.406 | -0.112 | 6.236 | 12/18/2026 | 0.100 | JP Morgan | ||
| JY0EK3 | Vertex Pharmaceuticals Inc./OS/Call [540]/JPMD | - | - | 540.000 | call | Vertex Pharmaceuticals Inc. | - | 40.097% | 0.427 | -0.106 | 5.679 | 01/15/2027 | 0.100 | JP Morgan | ||
| JY30EE | Vertex Pharmaceuticals Inc./OS/Call [540]/JPMD | - | - | 540.000 | call | Vertex Pharmaceuticals Inc. | - | 41.346% | 0.468 | -0.096 | 4.684 | 03/19/2027 | 0.100 | JP Morgan | ||
| JY3LSB | Vertex Pharmaceuticals Inc./OS/Call [540]/JPMD | - | - | 540.000 | call | Vertex Pharmaceuticals Inc. | - | 43.800% | 0.214 | -0.187 | 14.629 | 08/21/2026 | 0.100 | JP Morgan | ||
| SX5K5G | Vertex Pharmaceuticals Inc./OS/Call [540]/SOC | - | - | 540.000 | call | Vertex Pharmaceuticals Inc. | - | 39.018% | 0.425 | -0.103 | 5.813 | 01/15/2027 | 0.100 | Société Générale | ||
| FE1AXL | Vertex Pharmaceuticals Inc./OS/Call [540]/SOC | - | - | 540.000 | call | Vertex Pharmaceuticals Inc. | - | 38.672% | 0.273 | -0.141 | 11.320 | 09/18/2026 | 0.100 | Société Générale | ||
| FE58HE | Vertex Pharmaceuticals Inc./OS/Call [540]/SOC | - | - | 540.000 | call | Vertex Pharmaceuticals Inc. | - | 38.900% | 0.400 | -0.109 | 6.451 | 12/18/2026 | 0.100 | Société Générale | ||
| FE58HJ | Vertex Pharmaceuticals Inc./OS/Call [540]/SOC | - | - | 540.000 | call | Vertex Pharmaceuticals Inc. | - | 39.874% | 0.462 | -0.093 | 4.855 | 03/19/2027 | 0.100 | Société Générale | ||
| FE58U3 | Vertex Pharmaceuticals Inc./OS/Call [540]/SOC | - | - | 540.000 | call | Vertex Pharmaceuticals Inc. | - | 39.306% | 0.497 | -0.081 | 4.170 | 06/17/2027 | 0.100 | Société Générale |